NH THERAGUIX SAS

NH TherAguix SAS Stock

Stocks

ALNHT

FR0013105954

Market Closed - Euronext Paris Other stock markets 20:34:17 2021-10-21 EDT			5-day change	1st Jan Change
0.0100 ^EUR	-.--%		-.--%	-

24-09-03	NH TherAguix Announces Continuation of Phase II NANOBRAINMETS Trial in Treatment of Brain Metastases After Completion of Futility Analysis	CI
24-05-30	NH TherAguix Appoints Vincent Carrère as CEO	CI

Latest news : NH TherAguix SAS

24-09-03	NH TherAguix Announces Continuation of Phase II NANOBRAINMETS Trial in Treatment of Brain Metastases After Completion of Futility Analysis	CI
24-05-30	NH TherAguix Appoints Vincent Carrère as CEO	CI
24-05-30	NH TherAguix Announces AGuIX Receives Fast Track Designation from U.S. Food and Drug Administration	CI
21-10-28	NH TherAguix SAS and Carbogen AMCIS AG Announce the Release of New Batch of AGuIX Drug Product for Clinical Trials	CI

Press Releases: NH TherAguix SAS

24-06-18	NH TherAguix SAS : Nature’s Scientific Reports publishes an article describing the quantification of novel radio-enhancer AGuIX® developed in brain metastases	PU
23-12-19	NH TherAguix SAS : announces the publication of promising preclinical results of AGuIX® in combination with targeted radioligand therapies (TRT)	PU
23-09-12	NH TherAguix SAS : appoints Vincent Carrère as Chief Executive Officer	PU
23-07-20	NH TherAguix SAS : announces communications to be presented at the AAPM meeting by Harvard Medical Schools collaborators	PU
23-01-13	NH TherAguix SAS : announces the arrival of Aurélien Meyzaud as Head of Intellectual Property and Business Intelligence	PU

More press releases

News in other languages: NH TherAguix SAS

21-09-28

NhTherAguix: NH TherAguix annonce le lancement de son introduction en bourse sur le marché Euronext Growth à Paris

Managers and Directors: NH TherAguix SAS

Manager	Title	Age	Since
Vincent Carrère CEO	Chief Executive Officer	-	2023-08-31
Géraldine Le Duc CEO	Chief Executive Officer	-	2015-12-10
Caroline Cayre DFI	Director of Finance/CFO	-	2019-07-31

Director	Title	Age	Since
Géraldine Le Duc BRD	Director/Board Member	-	2019-02-21
Olivier Tillement BRD	Director/Board Member	-	2019-02-21
Hervé Eloi Dominique Brailly CHM	Chairman	64	2019-02-21

Financials

	2019	2020
Net sales	972K 854K 787K 736K 1.38M 91.72M 1.4M 9.44M 3.66M 45.21M 3.65M 3.57M 157M	1.32M 1.16M 1.07M 1M 1.88M 125M 1.91M 12.86M 4.98M 61.59M 4.97M 4.86M 214M
Net income	-2.7M -2.37M -2.19M -2.05M -3.84M -255M -3.91M -26.25M -10.17M -126M -10.15M -9.93M -437M	-4.34M -3.82M -3.52M -3.29M -6.17M -410M -6.28M -42.19M -16.34M -202M -16.32M -15.96M -702M
Net Debt	-	-

* Estimated data More financial data

Company Profile

Employees

14

Sector

-

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
ALNHT Stock

As early as today, start finding the best investment opportunities!